Toxicity and carcinogenicity of Δ9-tetrahydrocannabinol in Fischer rats and B6C3F1 mice

Fundamental and Applied Toxicology

Volumn 30, Issue 1, 1996, Pages 109-117

  Chan, P C ^a   Sills, R C ^a   Braun, A G ^b   Haseman, J K ^a   Bucher, J R ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b TSI Mason Research Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTERONE; DRONABINOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENICITY; CONTROLLED STUDY; CONVULSION; FEMALE; FIBROADENOMA; HYPERACTIVITY; HYPOPHYSIS ADENOMA; INTRAGASTRIC DRUG ADMINISTRATION; LEYDIG CELL; MALE; MOUSE; NONHUMAN; OVARY; PANCREAS; RAT; TESTIS ATROPHY; UTERUS;

ANIMALIA; RODENTIA; ZEA MAYS;

EID: 26844566936     PISSN: 02720590     EISSN: None     Source Type: Journal    
DOI: 10.1006/faat.1996.0048     Document Type: Article

References (26)

1. 9-THC on pregnancy and offspring in rats. Neurobehav. Toxicol. Teratol. 6, 29-32.
2. 9-tetrahydrocannabinol on pregnancy and offspring in the rat. Toxicol. Appl. Pharmacol. 20, 480-486.
3. Bornheim, L. M. (1989). Effect of cannabidiol on drug metabolism. In Biochemistry and Physiology of Substance Abuse (R. R. Watson, Ed.), Vol. 1, pp. 22-35. CRC Press, Boca Raton, FL.
4. Cox, D. (1972). Regression models and life tables. J. R. Sat. Soc. B34, 187-220.
5. Dunn, O. J. (1964). Multiple comparisons using rank sums. Technometrics 6, 241-252.
6. Dewey, W. L. (1986). Cannabinoid pharmacology. Pharmacol. Rev. 38, 151-173.
7. Eldridge, J. C., Murphy, L. L., and Landfield, P. W. (1991). Cannabinoids and the hippocampal glucocorticoid receptor: Recent findings and possible significance. Steroids 56, 226-231.
8. Gart, J., Chu, K., and Tarone, R. (1979). Statistical issues in interpretation of chronic bioassay tests for cardnogenicity. J. Natl. Cancer Inst. 62, 957-974.
9. Haseman, J. (1984). Statistica issues in the design, analysis and interpretation of animal card nogeni city studies. Environ. Health Perspect. 58, 385-392.
10. Haseman, J. K., Huff, J. E., Rao, G. N., Arnold, J. E., Boorman, G. A., and McConnell, E. E. (1985). Neoplasm observed in untreated and corn oil gavage control groups of F344/N rats and C57BL/6N × C3H/ HeN)F1(B6C3F1) mice. J. Natl. Cancer Inst. 75, 975-984.
11. Hollister, L. E. (1984). Health aspects of cannabis. Pharmacol. Rev. 38, 1-20.
12. Kari, F. W., and Abdo, A. (1995). The sensitivity of the NTP bioassay for carcinogen hazard evaluation can be mondulated by dietary restriction. In Dietary Restriction: Implications for the Design and Interpretation of Toxicity and Card nogeni city Studies (R. W. Hart, D. A. Neumann, and R. T. Robertson, Eds.), pp. 63-78. ILSI Press, Washington, DC.
13. 9-tetrahydrocannabinol: Possible mediation by glucocorticoid systems. Brain Res. 443, 47-62.
14. Luthra, Y. K., Rosenkrantz, H., Heyman, I. A., and Braude, M. C. (1975). Differential neurochemistry and temporal pattern in rats treated orally with delta9-tetrahydrocannabinol for periods up to six months. Toxicol. Appl. Pharmacol. 32, 418-431.
15. Martin, B. R. (1986). Cellular effects of cannabinoids. Pharmacol. Rev. 38, 45-74.
16. National Toxicology Program (NTP) (1994). Toxicology and Carcinogenesis Studies of 1-trans-delta9-Tetrahydrocannabinol in F344/N rats and B6C3F1 Mice, NTP Technical Report 446. U.S. Department of Heath and Human Services, Public Heath Service, National Institutes of Heath.
17. National Toxicology Program (NTP) (1995). The Effect of Dietary Restriction on Toxicology and Carcinogenesis Studies in F344/N rats and B6C3F1 Mice, NTP Technical Report 460. U.S. Department of Heath and Human Services, Public Heath Services, National Institutes of Heath.
18. Newton, S. C., Murphy, L. L., and Bartke, A. (1993). In vitro effects of psychoactive and non-psychoactive cannabinoids on immature rat Sertoli cell function. Life Sci. 53, 1429-1437.
19. Pertwee, R. G. (1991). Tolerance to and dependence on psychotropic cannabinoids. In The Biological Bases of Drug Tolerance and Dependence (J. A. Pratt, Ed.), pp. 231-263. Academic Press, New York.
20. Rosenkrantz, H., Sprague, R. A., Fleischman, R. W., and Braude, M. C. (1975). Oral dalta 9-THC toxicity in ras treated for period up to six months. Toxicol. Appl. Pharmacol. 32, 399-417.
21. Rosenkrantz, H., and Esber, H. J. (1980). Cannabinoid-induced hormone changes in monkeys and rats. J. Toxicol. Environ. Health 6, 297-313.
22. Shirley, E. (1977). A non-parametric equivalent of Williams' test for contrasting increasing dose levels of a treatment. Biometrics 33, 386-389.
23. Thompson, G. R., Mason, M. M., Rosenkrantz, H., and Braude, M. C. (1973). Chronic oral toxicity of cannabinoids in rats. Toxicol. Appl. Pharmacol. 25, 373-390.
24. 9-tetrahydrocannabinol in cultured rat granulosa cells. Toxicol. Appl. Pharmacol. 118, 53-57.
25. Turturro, K., Blank, D., Murasko, D., and Hart, R. (1994). Mechanisms of caloric restriction affecting aging and disease. Ann. N.Y Acad. Sci. 719, 159-170.
26. Zuardi, A. W., Teixeira, N. A., and Karniol, I. C. (1984). Pharmacological interaction of the effects of delta-9-trans-tetrahydrocannabinol and cannabidiol on serum corticosterone levas in rets. Arch. Int. Pharmacodyn. Ther. 269, 12-19.